Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Small Cell Lung Carcinoma 30Burkitt Lymphoma 12Lung Neoplasms 11Leukemia, Myeloid, Acute 11Recurrence 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Non-Hodgkin 7Hodgkin Disease 7Carcinoma, Non-Small-Cell Lung 7Neuroblastoma 4Lymphoma, B-Cell 4Leukemia 4Wilms Tumor 3Sarcoma, Ewing 3Plasmablastic Lymphoma 3Neoplasms, Germ Cell and Embryonal 3Neoplasms 3Myelodysplastic Syndromes 3Multiple Myeloma 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, T-Cell 3Lymphoma, Mantle-Cell 3Lymphoma, Follicular 3Immunoblastic Lymphadenopathy 3Ganglioneuroblastoma 3Teratoma 2Sarcoma 2

Interventions

Standard of Care 1Specimen Handling 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Nivolumab 1Magnetic Resonance Spectroscopy 1Etoposide 1Cisplatin 1Carboplatin 1Bleomycin 1Biopsy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endodermal Sinus Tumor × Etoposide × 90 days × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡